Drug intelligence / Profile preview

Cutemol

Development stage: Unknown
Lead developer: Summers Laboratories
Modality: Small Molecules
Administration: Topical

Overview

Cutemol is a line of over-the-counter (OTC) topical skincare products developed by Summers Laboratories for the management of severe dry skin, eczema, and psoriasis. The formulations, which include creams and lotions, primarily utilize natural beeswax as an occlusive agent to create a protective barrier on the skin, locking in moisture and preventing transepidermal water loss. The Cutemol CM variant features a Cutewax Ceramide Complex, which includes ceramides and cholesterol to support and repair the skin's natural lipid barrier. These products have been recommended by dermatologists for over 20 years as effective treatments for compromised skin conditions.

Brand names: Cutemol Emollient CreamCutemol Moisturizing LotionCutemol SensitiveCutemol CM

Beyond the preview

Go deeper on Cutemol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutemol.

Explore the full profile